Healthcare provider profile · identity verified

David Kaiden, MD

Family Practice · SAN DIEGO, CA · NPI 1548312911

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	590	225
Rosuvastatin Calcium	Rosuvastatin Calcium	481	194
Lisinopril	Lisinopril	423	155
Amlodipine Besylate	Amlodipine Besylate	422	169
Losartan Potassium	Losartan Potassium	339	139
Levothyroxine Sodium	Levothyroxine Sodium	338	137
Metformin Hcl Er	Metformin Hcl	225	89
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	213	58
Omeprazole	Omeprazole	195	70
Tamsulosin Hcl	Tamsulosin Hcl	182	74
Trazodone Hcl	Trazodone Hcl	169	57
Simvastatin	Simvastatin	156	60
Metoprolol Tartrate	Metoprolol Tartrate	154	60
Meloxicam	Meloxicam	143	65
Potassium Chloride	Potassium Chloride	139	56
Terazosin Hcl	Terazosin Hcl	138	53
Metformin Hcl	Metformin Hcl	134	52
Hydrochlorothiazide	Hydrochlorothiazide	129	57
Glipizide	Glipizide	126	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	126	47
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	124	27
Alendronate Sodium	Alendronate Sodium	120	56
Gabapentin	Gabapentin	120	48
Pradaxa	Dabigatran Etexilate Mesylate	116	41
Atenolol	Atenolol	113	42
Furosemide	Furosemide	108	44
Sertraline Hcl	Sertraline Hcl	92	37
Jardiance	Empagliflozin	88	30
Allopurinol	Allopurinol	81	34
Pantoprazole Sodium	Pantoprazole Sodium	79	28
Ondansetron Odt	Ondansetron	70	19
Alprazolam	Alprazolam	68	20
Lorazepam	Lorazepam	65	22
Duloxetine Hcl	Duloxetine Hcl	64	28
Prednisone	Prednisone	61	53
Albuterol Sulfate Hfa	Albuterol Sulfate	60	47
Finasteride	Finasteride	60	24
Triamcinolone Acetonide	Triamcinolone Acetonide	60	43
Cefadroxil	Cefadroxil	56	51
Ozempic	Semaglutide	56	24
Mirtazapine	Mirtazapine	53	20
Ipratropium Bromide	Ipratropium Bromide	49	19
Clopidogrel	Clopidogrel Bisulfate	47	20
Estradiol	Estradiol	45	27
Acyclovir	Acyclovir	44	23
Famotidine	Famotidine	43	16
Carvedilol	Carvedilol	42	15
Doxycycline Monohydrate	Doxycycline Monohydrate	42	37
Humulin N	Insulin Nph Human Isophane	41	14
Bupropion Xl	Bupropion Hcl	40	15
Montelukast Sodium	Montelukast Sodium	40	14
Citalopram Hbr	Citalopram Hydrobromide	37	16
Metoprolol Succinate	Metoprolol Succinate	37	15
Spironolactone	Spironolactone	37	15
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	36	36
Wixela Inhub	Fluticasone Propion/Salmeterol	36	15
Eliquis	Apixaban	35	13
Sumatriptan Succinate	Sumatriptan Succinate	35	13
Hydralazine Hcl	Hydralazine Hcl	34	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	13
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	14
Propranolol Hcl	Propranolol Hcl	32	suppressed
Alvesco	Ciclesonide	31	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	26
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Hydrocortisone	Hydrocortisone	29	19
Ezetimibe	Ezetimibe	27	suppressed
Testosterone	Testosterone	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	15
Humulin N Kwikpen	Insulin Nph Human Isophane	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Cephalexin	Cephalexin	23	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	11
Colchicine	Colchicine	22	13
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Victoza 2-Pak	Liraglutide	22	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	21	21
Buspirone Hcl	Buspirone Hcl	21	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	suppressed
Fluocinonide	Fluocinonide	20	13
Ibuprofen	Ibuprofen	20	13
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Liraglutide	Liraglutide	16	suppressed
Mupirocin	Mupirocin	16	13
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Humulin R	Insulin Regular, Human	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Amoxicillin	Amoxicillin	14	13
Tadalafil	Tadalafil	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Temazepam	Temazepam	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Risperidone	Risperidone	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Azithromycin	Azithromycin	11	11
Epinephrine	Epinephrine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error